Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: Is it time to change the drug development process in order to increase productivity?

por Burt, Tal, Roffel, Ad F., Langer, Oliver, Anderson, Kirsten, DiMasi, Joseph
Publicado 2022

Assessing the Financial Value of Decentralized Clinical Trials

por DiMasi, Joseph A., Smith, Zachary, Oakley-Girvan, Ingrid, Mackinnon, Andrew, Costello, Mary, Tenaerts, Pamela, Getz, Kenneth A.
Publicado 2022

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial

por Stergiopoulos, Stella, Calvert, Sara B, Brown, Carrie A, Awatin, Josephine, Tenaerts, Pamela, Holland, Thomas L, DiMasi, Joseph A, Getz, Kenneth A
Publicado 2018

Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project

por Levitan, Bennett, Getz, Kenneth, Eisenstein, Eric L., Goldberg, Michelle, Harker, Matthew, Hesterlee, Sharon, Patrick-Lake, Bray, Roberts, Jamie N., DiMasi, Joseph
Publicado 2017